Chemistry Reference
In-Depth Information
116. Boghra, R.J., Kothawade, P.C., Belgamwar, V.S., Nerkar, P.P., Tekade, A.R., and Surana,
S.J. (2011) Solubility, dissolution rate and bioavailability enhancement of irbesartan by solid
dispersion technique.
Chem. Pharm. Bull.
, 59(4):438-441.
117. Hsieh, Y.L., Ilevbare, G.A., Van Eerdenbrugh, B., Box, K.J., Sanchez-Felix, M.V., and
Taylor, L.S. (2012) PH-induced precipitation behavior of weakly basic compounds: deter-
mination of extent and duration of supersaturation using potentiometric titration and
correlation to solid state properties.
Pharm. Res.
, 29(10):2738
2753.
118. Karavas, E., Georgarakis, E., and Bikiaris, D. (2006) Felodipine nanodispersions as active
core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer.
Int. J. Pharm.
, 313(1-2):189-197.
119. Ilevbare, G.A., Liu, H., Pereira, J., Edgar, K.J., and Taylor, L.S. (2013) Influence of additives
on the properties of nanodroplets formed in highly supersaturated aqueous solutions of
ritonavir.
Mol. Pharm.
, 10(9):3392-3403.
120. Tachibana, T. and Nakamura, A. (1965) A method for preparing an aqueous colloidal
dispersion of organic materials by using water-soluble polymers: dispersion B-carotene by
polyvinylpyrrolidone.
Kolloid-Zeit. Zeit. Polym.
, 203(2):130-133.
121. Aisha, A.F.A., Ismail, Z., Abu-salah, K.M., and Majid, A.M.S.A. (2012) Solid dispersions
of
α
-mangostin improve its aqueous solubility through self-assembly of nanomicelles.
J. Pharm. Sci.
, 101(2):815-825.
122. Frank, K.J., Westedt, U., Rosenblatt, K.M., et al. (2012) The amorphous solid dispersion of
the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium:
impact on solubility.
Int. J. Nanomed.
, 7:5757-5768.
123. Brick, M.C., Palmer, H.J., and Whitesides, T.H. (2003) Formation of colloidal dispersions of
organic materials in aqueous media by solvent shifting.
Langmuir
, 19(16):6367-6380.
124. Van Eerdenbrugh, B., Baird, J.A., and Taylor, L.S. (2010) Crystallization tendency of
active pharmaceutical ingredients following rapid solvent evaporation: classi
cation and
comparison with crystallization tendency from undercooled melts.
J. Pharm. Sci.
, 99(9):
3826-3838.
125. Baird, J.A., Van Eerdenbrugh, B., and Taylor, L.S. (2010) A classi
-
cation system to assess
the crystallization tendency of organic molecules from undercooled melts.
J. Pharm. Sci.
,
99(9):3787
3806.
126. Murdande, S.B., Pikal, M.J., Shanker, R.M., and Bogner, R.H. (2011) Solubility advantage
of amorphous pharmaceuticals: Part 3. Is maximum solubility advantage experimentally
attainable and sustainable?
J. Pharm. Sci.
, 100(10):4349-4356.
127. Douroumis, D. and Fahr, A. (2007) Stable carbamazepine colloidal systems using the
cosolvent technique.
Eur. J. Pharm. Sci.
, 30(5):367-374.
128. Goddard, E.D., Turro, N.J., Kuo, P.L., and Ananthapadmanabhan, K.P. (1985) Fluorescence
probes for critical micelle concentration determination.
Langmuir
, 1(3):352-355.
129. Zhao, C.L., Winnik, M.A., Riess, G., and Croucher, M.D. (1990) Fluorescence probe
techniques used to study micelle formation in water-soluble block copolymers.
Langmuir
,
6(2):514-516.
130. Van Eerdenbrugh, B., Alonzo, D.E., and Taylor, L.S. (2011) Influence of particle size on the
ultraviolet spectrum of particulate-containing solutions: implications for
in-situ
concentra-
tion monitoring using UV/vis fiber-optic probes.
Pharm. Res.
, 28(7):1643-1652.
131. Yamashita, K., Nakate, T., Okimoto, K., et al. (2003) Establishment of new preparation
method for solid dispersion formulation of tacrolimus.
Int. J. Pharm.
, 267(1-2):79-91.
-
